IPRIPR2023-00620Institution Denied
Celltrion, Inc.v.Regeneron Pharmaceuticals, Inc.
IPR challenge of US 10406226.
Type
IPR
Filed
Feb 28, 2023
Instituted
Sep 1, 2023
Decided
Sep 1, 2023
Patent
Application
15692893
Inventor
Daniel B. DIX et al
Granted
Sep 10, 2019
01
Timeline
3 milestones
2023-02-28Petition filed
2023-09-01Institution
2023-09-01Terminated
02
Parties & counsel
Petitioner
Celltrion, Inc.
Counsel
Green, Loraet al
Patent Owner
Regeneron Pharmaceuticals, Inc.
Counsel
Fishman, Deborahet al
03
Docket
Documents are mirrored from the PTAB e-file system. Filer is as stated on the face of the filing.
SOURCE · USPTO PTAB E2EView on Unified Patents →